Issues & Advocacy

In 2010, MDMA will focus its advocacy efforts on improving the legislative and regulatory environment for medical technology innovators.  The four primary platforms of MDMA’s 2010 Public Policy Agenda include: minimizing the impact of the health care reform and advocating for the removal of the medical device tax; preserving strong intellectual property laws which promote innovation; ensuring patients and caregivers have open access to innovative technologies that are safe and effective through a predictable FDA process; and improving the Medicare coverage, coding and payment processes to promote timely and adequate reimbursement for innovative technology.

MDMA Advocacy

An understanding and awareness of the policy discussions taking place in Washington related to the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS) and other federal agencies is a must for medical technology executives. The decisions made in Washington can impact your company for many years to come. Lack of participation is not an option for the long term viability of the entrepreneurial sector of the industry.

For the past 18 years, MDMA has grown from a one issue organization to an effective advocate on every major issue affecting the innovative sector of the medical technology industry. We would like to remind our members of the importance of having their voices heard on Capitol Hill.

Working Groups

We invite all of our member companies to participate on one or more of MDMA’s Working Groups. These groups address the many challenges facing innovative medical device companies. Each working group meets monthly via conference call and receives additional email updates and breaking news on a consistent basis.  Current MDMA Working Groups include:

  • Coverage and Reimbursement
  • FDA
  • Market Access
  • Gainsharing
  • Patent
  • International Issues (quarterly)

If you are a MDMA member and would like to participate in a working group please email your participation prefernce and you will be added to the group.

Legislative Action Center

The importance of smaller companies being represented in Washington cannot be overstated. MDMA is constantly monitoring legislation and regulations that can impact the medical technology community, and consistently represents the collective interests of our membership. However, our ability to impact policy decisions is directly related to how much participation we have from our members. MDMA's Legislative Action Center provides tools which allow members to quickly and easily contact their elected officials, local and national media and colleagues in industry on important issues and pending legislation.